Researchers at Lund University in Sweden, have in collaboration with colleagues in Copenhagen and Singapore, mapped how the body’s own peptides act to reduce infection and inflammation by deactivating the toxic substances formed in the process.
The study is published in Nature Communications and the researchers believe their discovery could lead to new drugs against infection and inflammation, for example in wound healing.
The toxins that are neutralised, known as lipopolysaccharides (LPS), come from the bacterial cell walls and generate an inflammatory reaction. The reaction is a necessary part of our immune defence system in which our bodies respond quickly and fight invasive bacteria. However, it can be over-activated and become harmful, as observed in infected skin wounds, infections in various organs, or in the case of bacteria spreading to the blood, which can lead to sepsis.
“We know from previous studies what the task of these peptides is but now we have mapped how they proceed in gradually reducing an inflammatory reaction”, says Artur Schmidtchen, professor of dermatology and venereology at Lund University and consultant physician at Skåne University Hospital in Lund.
“By use of advanced biophysics such as nuclear magnetic resonance analysis, combined with molecular modelling and biological studies we show that these peptides form a C-shaped structure which enables the capturing and inactivation of LPS. They also simultaneously interfere with receptor-mediated inflammatory responses”, adds Rathi Saravanan, senior research fellow at Lee Kong Chian School of Medicine at Nanyang Technological University, Singapore, and first author of the study.
“Currently, most drugs aim to more or less completely block a target, such as a receptor. But that risks a deactivation of the immune defence system which can be detrimental and downright dangerous. The body’s own defence mechanisms proceed with greater caution in what is known as a transient manner: the peptides act on their target for a short time to reduce an inflammation towards normalisation. It is the natural functions of these peptides that we want to develop into new drugs”, says Artur Schmidtchen, who has been researching the field of innate immunity for over 20 years.
In addition, the peptides present in thrombin, a common blood protein, are multifunctional and can attack several targets, unlike current drugs.
The dermatology researchers now want to develop a peptide gel for improved wound healing in patient studies.
“That is the primary goal, but we will also be looking at the possibility of developing new drugs against infections in the eyes and various internal organs. This will become a new way of preventing both infection and inflammation without using antibiotics.”
Learn more: The medicine of the future against infection and inflammation?
The Latest on: Peptides
[google_news title=”” keyword=”peptides” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Peptides
- New imaging technique provides a much closer look at fibril assemblieson April 26, 2024 at 10:47 pm
A new imaging technique developed by engineers at Washington University in St. Louis can give scientists a much closer look at fibril assemblies, stacks of peptides like amyloid beta, most notably ...
- Best anti-aging eye creams to help you turn back the clockon April 26, 2024 at 8:57 pm
Our guide to the best anti-aging eye creams will help you to rejuvenate the skin around your eyes and reduce the signs of aging, with clinically proven results.
- The Best Peptide Serum for Every Skin Type and Concernon April 26, 2024 at 8:20 am
It’s also helpful to consider the peptide in the serum. Signal peptides and carrier peptides currently have the most evidence to back up their anti-aging benefits—with copper peptides being among the ...
- Scientists learn from caterpillars how to create self-assembling capsules for drug deliveryon April 26, 2024 at 8:00 am
Self-assembling molecules that spontaneously organize themselves to form complex structures are common in nature. For example, the tough outer layer of insects, called the cuticle, is rich in proteins ...
- UW’s Baker Lab researchers make AI strides in drug-like peptideson April 25, 2024 at 10:59 am
In recent years, artificial intelligence programs for drug design have steadily shown they can help explore far beyond just small-molecule drugs—by illuminating how proteins fold and interact, all | ...
- Engineers muffle invading pathogens with a 'molecular mask'on April 24, 2024 at 8:00 am
Vaccines remain the gold standard of protection against dangerous pathogens, but take considerable time and vast resources to develop. Rapidly mutating viruses such as SARS-CoV-2 can blunt their ...
- Self-assembling synthetic cells act like living cells with extra abilitieson April 23, 2024 at 5:00 pm
For the new study, scientists from the University of North Carolina at Chapel Hill developed synthetic, self-assembling cytoskeletons, built out of DNA, peptides and other genetic material. “DNA does ...
- Umbrella Labs Elevates Biotechnological Frontiers with Launch of ALPHA MSH PEPTIDE 10MG VIALon April 23, 2024 at 2:52 pm
Tucson, Arizona - Umbrella Labs Sets New Industry Standards with Pharmaceutical Grade SARMS and Peptides - The ALPHA MSH PEPTIDE 10MG VIAL from Umbrella Labs represents a sea change in the field of ...
- Tau Toggling Peptides: One Seeds Fibrils; the Other Dismantles Themon April 19, 2024 at 4:36 pm
Destructive Relief. In the proposed strain relief mechanism, left-twisted tau fibrils bind D-peptides, which initially adopt tau’s left-handed twist to form paired fibrils. Structurally strained, ...
via Bing News